Viewing Study NCT02767661


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2026-01-25 @ 3:12 AM
Study NCT ID: NCT02767661
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-16
First Post: 2016-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module